UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Absence of large intragenic rearrangements in the DPYD gene in a large cohort of colorectal cancer patients treated with 5‐FU‐based chemotherapy

British journal of clinical pharmacology, 2010-08, Vol.70 (2), p.268-272

2010

Volltextzugriff (PDF)

Abstract 2610: TYMS and XRCC1 gene polymorphisms as possible predictors for the addition of oxaliplatin to 5FU in the adjuvant treatment of stage II and III colorectal cancer

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.2610-2610

2010

Volltextzugriff (PDF)

Afectación valvular tricuspídea y pulmonar en un caso de síndrome carcinoide

Revista española de cardiologia, 1997, Vol.50 (7), p.532-534

1997

Volltextzugriff (PDF)

Analysis of differential gene expression in human colorectal tumor tissues by RNA arbitrarily primed-PCR: a technical assessment

Laboratory investigation, 1998-03, Vol.78 (3), p.309

1998

Volltextzugriff (PDF)

Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial

The lancet oncology, 2013-10, Vol.14 (11), p.1077-1085

2013

Volltextzugriff (PDF)

Bladder Preservation Strategy Based on Combined Therapy in Patients with Muscle-Invasive Bladder Cancer: Management and Results at Long-Term Follow-Up

Urologia internationalis, 2010-01, Vol.85 (3), p.281-286

2010

Volltextzugriff (PDF)

Cáncer colorrectal con metástasis hepáticas sincrónicas: ¿cuán agresivos podemos ser?

Cirugia Española, 2004, Vol.76 (2), p.117-119

2004

Volltextzugriff (PDF)

Carboplatin for advanced bladder cancer

European journal of cancer & clinical oncology, 1990, Vol.26 (7), p.849-850

1990

Volltextzugriff (PDF)

Celecoxib induces anoikis in human colon carcinoma cells associated with the deregulation of focal adhesions and nuclear translocation of p130Cas

International journal of cancer, 2006-05, Vol.118 (10), p.2381-2389

2006

Volltextzugriff (PDF)

Circulating Tumor Cell Count Is a Prognostic Factor in Metastatic Colorectal Cancer Patients Receiving First‐Line Chemotherapy Plus Bevacizumab: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study

The oncologist (Dayton, Ohio), 2012-07, Vol.17 (7), p.947-955

2012

Volltextzugriff (PDF)

Cirugía secuencial inversa después de quimioterapia neoadyuvante por metástasis hepáticas sincrónicas de cáncer colorrectal

Cirugia Española, 2007-10, Vol.82 (4), p.235-237

2007

Volltextzugriff (PDF)

Colorectal cancer metastasis resectability after treatment with the combination of oxaliplatin, irinotecan and 5-fluorouracil. Final results of a phase II study

Acta oncologica, 2008, Vol.47 (2), p.286-292

2008

Volltextzugriff (PDF)

Colorectal cancer OncoGuia

Clinical & translational oncology, 2010-03, Vol.12 (3), p.188-210

2010

Volltextzugriff (PDF)

Colorectal Cancer OncoGuia: surgical pathology report guidelines

Clinical & translational oncology, 2010-03, Vol.12 (3), p.211-213

2010

Volltextzugriff (PDF)

Description and management of cutaneous side effects during cetuximab or erlotinib treatments: A prospective study of 30 patients

Journal of the American Academy of Dermatology, 2006-09, Vol.55 (3), p.429-437

2006

Volltextzugriff (PDF)

Efficacy and safety according to age subgroups in AVEX, a randomized phase III trial of bevacizumab in combination with capecitabine for the first-line treatment of elderly patients with metastatic colorectal cancer

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.3521-3521

2013

Volltextzugriff (PDF)

Electromagnetic imaging of a transpressional tectonics in SW Iberia

Geophysical research letters, 2001-02, Vol.28 (3), p.439-442

2001

Volltextzugriff (PDF)

First‐Line Cetuximab Plus Capecitabine in Elderly Patients with Advanced Colorectal Cancer: Clinical Outcome and Subgroup Analysis According to KRAS Status from a Spanish TTD Group Study

The oncologist (Dayton, Ohio), 2012-03, Vol.17 (3), p.339-345

2012

Volltextzugriff (PDF)

Genetic pathways and genome-wide determinants of clinical outcome in colorectal cancer

Cancer research (Chicago, Ill.), 2003-11, Vol.63 (21), p.7206-7214

2003

Volltextzugriff (PDF)

Immunoglobulin G fragment C receptor polymorphisms and KRAS mutations: Are they useful biomarkers of clinical outcome in advanced colorectal cancer treated with anti‐EGFR‐based therapy?

Cancer science, 2010-09, Vol.101 (9), p.2048-2053

2010

Volltextzugriff (PDF)

Intron splice acceptor site polymorphism in the hMSH2 gene in sporadic and familial colorectal cancer

British journal of cancer, 2000-02, Vol.82 (3), p.535-537

2000

Volltextzugriff (PDF)

Inversion of the sequence of surgery after neoadjuvant chemotherapy for synchronous liver metastases from colorectal cancer

Cirugia Española, 2007-10, Vol.82 (4), p.235-237

2007

Volltextzugriff (PDF)

Irinotecan in Combination With Fluorouracil in a 48-Hour Continuous Infusion As First-Line Chemotherapy for Elderly Patients With Metastatic Colorectal Cancer: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study

Journal of clinical oncology, 2005-05, Vol.23 (15), p.3545-3551

2005

Volltextzugriff (PDF)

Irinotecan Pharmacogenetics: Influence of Pharmacodynamic Genes

Clinical cancer research, 2008-03, Vol.14 (6), p.1788-1796

2008

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(52)

Sprache

Englisch
(44)
Spanisch
(8)

Erscheinungsjahr

n.n

Thema

Humans
(36)
Science & Technology
(36)
Life Sciences & Biomedicine
(33)
Male
(31)
Oncology
(30)
Aged
(29)
Female
(28)
Middle Aged
(26)
Biological And Medical Sciences
(21)
Medical Sciences
(21)
Adult
(19)
Aged, 80 And Over
(19)
Colorectal Neoplasms - Pathology
(18)
Tumors
(16)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(15)
Colorectal Neoplasms - Drug Therapy
(15)
Colorectal Cancer
(14)
Colorectal Neoplasms - Genetics
(14)
Treatment Outcome
(12)
Fluorouracil - Administration & Dosage
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Absence of large intragenic rearrangements in the DPYD gene in a large cohort of colorectal cancer patients treated with 5‐FU‐based chemotherapy

Abstract 2610: TYMS and XRCC1 gene polymorphisms as possible predictors for the addition of oxaliplatin to 5FU in the adjuvant treatment of stage II and III colorectal cancer

Afectación valvular tricuspídea y pulmonar en un caso de síndrome carcinoide

Analysis of differential gene expression in human colorectal tumor tissues by RNA arbitrarily primed-PCR: a technical assessment

Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial

Bladder Preservation Strategy Based on Combined Therapy in Patients with Muscle-Invasive Bladder Cancer: Management and Results at Long-Term Follow-Up

Cáncer colorrectal con metástasis hepáticas sincrónicas: ¿cuán agresivos podemos ser?

Carboplatin for advanced bladder cancer

Celecoxib induces anoikis in human colon carcinoma cells associated with the deregulation of focal adhesions and nuclear translocation of p130Cas

Circulating Tumor Cell Count Is a Prognostic Factor in Metastatic Colorectal Cancer Patients Receiving First‐Line Chemotherapy Plus Bevacizumab: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study

Cirugía secuencial inversa después de quimioterapia neoadyuvante por metástasis hepáticas sincrónicas de cáncer colorrectal

Colorectal cancer metastasis resectability after treatment with the combination of oxaliplatin, irinotecan and 5-fluorouracil. Final results of a phase II study

Colorectal cancer OncoGuia

Colorectal Cancer OncoGuia: surgical pathology report guidelines

Description and management of cutaneous side effects during cetuximab or erlotinib treatments: A prospective study of 30 patients

Efficacy and safety according to age subgroups in AVEX, a randomized phase III trial of bevacizumab in combination with capecitabine for the first-line treatment of elderly patients with metastatic colorectal cancer

Electromagnetic imaging of a transpressional tectonics in SW Iberia

First‐Line Cetuximab Plus Capecitabine in Elderly Patients with Advanced Colorectal Cancer: Clinical Outcome and Subgroup Analysis According to KRAS Status from a Spanish TTD Group Study

First‐Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single‐Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study

Genetic pathways and genome-wide determinants of clinical outcome in colorectal cancer

Immunoglobulin G fragment C receptor polymorphisms and KRAS mutations: Are they useful biomarkers of clinical outcome in advanced colorectal cancer treated with anti‐EGFR‐based therapy?

Intron splice acceptor site polymorphism in the hMSH2 gene in sporadic and familial colorectal cancer

Inversion of the sequence of surgery after neoadjuvant chemotherapy for synchronous liver metastases from colorectal cancer

Irinotecan in Combination With Fluorouracil in a 48-Hour Continuous Infusion As First-Line Chemotherapy for Elderly Patients With Metastatic Colorectal Cancer: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study

Irinotecan Pharmacogenetics: Influence of Pharmacodynamic Genes

Suchergebnisse filtern